Literature DB >> 2331688

Trisomy 3 in cold agglutinin disease.

J Gordon1, L Silberstein, L Moreau, P C Nowell.   

Abstract

Cold agglutinin disease (CAD) is a form of autoimmune hemolytic anemia generally considered to result from an antibody-producing clonal expansion of B lymphocytes. We studied 16 patients with CAD and demonstrated a chromosomally abnormal clone in the peripheral blood (PB) of six. Trisomy 3 was the only abnormality in two patients, trisomy 12 the only abnormality in one, and both trisomy 3 and trisomy 12 were present in three patients. A lymphoma was subsequently diagnosed in two of these six patients and in none of the patients without a karyotypic abnormality. The results suggest that trisomy 3 confers a slight growth advantage in the B-cell lineage, particularly at a relatively late stage of differentiation. The resultant clone may present clinically as CAD and, in some cases, progress to a clinical lymphoma.

Entities:  

Mesh:

Year:  1990        PMID: 2331688     DOI: 10.1016/0165-4608(90)90013-z

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Cold agglutinin-associated B-cell lymphoproliferative disease shows highly recurrent gains of chromosome 3 and 12 or 18.

Authors:  Agnieszka Małecka; Jan Delabie; Ingunn Østlie; Anne Tierens; Ulla Randen; Sigbjørn Berentsen; Geir E Tjønnfjord; Gunhild Trøen
Journal:  Blood Adv       Date:  2020-03-24

2.  Occurrence of lymphoplasmacytic lymphoma 6 years after amelioration of primary cold agglutinin disease by rituximab therapy.

Authors:  Hiroaki Tanaka; Shinichiro Hashimoto; Yasumasa Sugita; Shio Sakai; Yusuke Takeda; Daijiro Abe; Toshiyuki Takagi; Chiaki Nakaseko
Journal:  Int J Hematol       Date:  2012-08-11       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.